S756 Excess Non-COVID Mortality Among IBD Decedents During the COVID-19 Pandemic

Abstract

a CRM was defined as RBS 5 0 and SFS #1 point (and a decrease of $1 point from the baseline SFS) and mucosal endoscopy subscore #1 without friability. b CRS was defined as reduction of 3-component Mayo score of $2 points and at least 35%, and reduction in RBS of #1 point or an absolute RBS of #1. c Denominators for OC were based on the number of pts who completed Week 46. d Denominators for NRI were based on the number of pts who completed Week 46 of the OLE and those who withdrew before Week 46 but would have reached Week 46 if they had stayed. This did not include the number of pts in the OLE who have not yet completed Week 46 or who discontinued and would not have reached Week 46 by this data cutoff. e Endoscopy subscore of #1 point. f Clinical remission while off corticosteroids for $12 weeks. CRM, clinical remission; CRS, clinical response; CRS only, clinical response but not remission; RBS, rectal bleeding subscore; SFS, stool frequency subscore.